Torrent Pharmaceuticals Limited

TORNTPHARM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20264,145

    Quarter₹ croreYoY
    Sept 20242,434+13.4%
    Dec 20242,377+12.0%
    Mar 20252,433+13.5%
    Jun 20252,616+7.3%
    Sept 20252,762+13.5%
    Dec 20252,599+9.3%
    Mar 20262,735+12.4%
    Jun 20264,158+58.9%
    Sept 20264,145+50.1%
  • ₹ crore

    Sept 2026-11

    Quarter₹ crore
    Sept 2024-7
    Dec 20243
    Mar 202515
    Jun 2025-5
    Sept 2025-27
    Dec 2025-8
    Mar 202658
    Jun 2026-21
    Sept 2026-11
  • ₹ crore

    Sept 20264,134

    Quarter₹ crore
    Sept 20242,427
    Dec 20242,380
    Mar 20252,448
    Jun 20252,611
    Sept 20252,735
    Dec 20252,591
    Mar 20262,793
    Jun 20264,137
    Sept 20264,134
  • Cost structure
  • ₹ crore

    Sept 2026669

    Quarter₹ crore
    Sept 2024407
    Dec 2024407
    Mar 2025416
    Jun 2025453
    Sept 2025460
    Dec 2025479
    Mar 2026487
    Jun 2026677
    Sept 2026669
  • ₹ crore

    Sept 20263,448

    Quarter₹ crore
    Sept 20241,757
    Dec 20241,729
    Mar 20251,802
    Jun 20251,869
    Sept 20251,916
    Dec 20251,824
    Mar 20262,154
    Jun 20263,453
    Sept 20263,448
  • Exceptional items and tax
  • ₹ crore

    Sept 2026676

    Quarter₹ crore
    Sept 2024670
    Dec 2024651
    Mar 2025622
    Jun 2025742
    Sept 2025806
    Dec 2025757
    Mar 2026592
    Jun 2026663
    Sept 2026676
  • ₹ crore

    Sept 2026178

    Quarter₹ crore
    Sept 2024210
    Dec 2024166
    Mar 2025148
    Jun 2025191
    Sept 2025209
    Dec 2025180
    Mar 2026125
    Jun 2026171
    Sept 2026178
  • Profit
  • ₹ crore

    Sept 2026498

    Quarter₹ croreYoY
    Sept 2024460+40.7%
    Dec 2024485+63.3%
    Mar 2025474+15.6%
    Jun 2025551+17.5%
    Sept 2025597+29.8%
    Dec 2025577+19.0%
    Mar 2026467-1.5%
    Jun 2026492-10.7%
    Sept 2026498-16.6%
  • Per share
  • ₹ per share

    Sept 202613.09

    Quarter₹ per share
    Sept 202413.60
    Dec 202414.33
    Mar 202514.00
    Jun 202516.28
    Sept 202517.64
    Dec 202517.04
    Mar 202613.80
    Jun 202612.94
    Sept 202613.09
  • Leverage
  • Debt to equity

    times

    Mar 20250.00x

    Quartertimes
    Sept 2024—
    Dec 2024—
    Mar 20250.00x
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
2,4342,3772,4332,6162,7622,5992,7354,1584,145
Revenue YoY+13.4%+12.0%+13.5%+7.3%+13.5%+9.3%+12.4%+58.9%+50.1%
-7315-5-27-858-21-11
2,4272,3802,4482,6112,7352,5912,7934,1374,134
Cost structure
407407416453460479487677669
1,7571,7291,8021,8691,9161,8242,1543,4533,448
Exceptional items and tax
670651622742806757592663676
210166148191209180125171178
Profit
460485474551597577467492498
Net profit YoY+40.7%+63.3%+15.6%+17.5%+29.8%+19.0%-1.5%-10.7%-16.6%
Per share
13.6014.3314.0016.2817.6417.0413.8012.9413.09
Leverage
Debt to equity——0.00x——————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.